Marburg virus DNA vaccine - GenPhar
Latest Information Update: 04 Nov 2017
At a glance
- Originator GenPhar
- Developer GenPhar; United States Army Medical Research Institute of Infectious Diseases
- Class DNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Marburg virus disease
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Marburg virus disease in USA
- 23 Nov 2006 Clinical trials in Marburg virus disease in USA (unspecified route)
- 23 Oct 2002 Preclinical trials in Marburg virus disease in USA (unspecified route)